HTG2014-Section-Header-publications

Categories

Filter by Topics

1L therapy; bispecific antibodies 478P TA-ness ABC- type ADCC Gene Alteration adolescents AI alcohol consumption ALK alzheimer's Angiogenesis Anti-TNF Alpha Therapy antibody drug conjugates antiEGFR apoptosis Apoptosis Asthma Autocrine Signaling Autoimmune Disorder Avelumab B Cells BCL2A1 BCL6 benign Biofluid Biology of neoplasia biomarker Biomarker Biomarker Analysis Biomarker Discovery Biomarker Validation biomarkers Biomarkers Bladder Bladder Cancer Bladder cancer Blastic plasmacytoid dandritic cell neoplasm BPDCN Blood Brain Breast Cancer Breast milk Burkitt lymphoma cancer genetics Cancer Genomics CAR-T-cells Cardiovascular Disease Castleman Disease CD10 CD3 CD8 CDKN1A CDKN2A mutation Cell Free Plasma Cells Cerebrospinal Fluid Chemokines Childhood Atopic Dermatitis chronic kidney disease Chronic Obstructive Pulmonary Disease Circulating miRNAs circulating tumor Circulating tumor cells classifications cMET cognition Colon Colon cancer Colorectal cancer Comparative Study Comparison study computational toxicology Core Needle Biopsy COVID-19 Custom mRNA cyclic AMP‑dependent transcription factor ATF‑4 Cytokine Cytokines Cytotoxic T Cells cytotoxicity Dementia dementia Developmental Immunotherapy Developmental Therapeutics Diabetes diabetic nephropathy Differential Expression Differential Gene Expression Analysis Diffuse Large B-Cell Lymphoma diffuse large B-cell lymphoma DLBCL DLBCL COO DNA damage‑inducible transcript 3 protein DNA lymphoma Drug Response Drug Safety Drug Targets Drug-induced Liver Injury Efficacy EGFR Muatations EMT Encephalophy end stage kidney disease Endothelial cell epidemiology epidermal growth factor receptor EGFRHER epigenomics Epstein-Barr ERBB3 Esophageal Cancer Exosomes extracellular miRNAs Extracellular Vesicles extraction-free RNA workflow Fabry Disease Feasibility FFPE FGF Ligand Trap FGFR Fibrous Tumors Follicular lymphoma GEIS gene expression Gene Expression gene expression profiling Gene Expression Profiling Gene Fusions Gene Signature Analysis Genetic Polymorphism Genitourinary cancer Glioblastoma Tumors HCC Head and Neck Cancer Heart hepatocellular carcinoma HER-2 HER2 HER2- Histone Deacetylase Inhibitors HLA-E Homing HPV HR+ HTG EdgeSeq HTG EdgeSeq ALKPlus Assay EU HTG EdgeSeq Custom Assays HTG EdgeSeq DLBCL Cell of Origin Assay HTG EdgeSeq DLBCL Cell of Origin Assay EU HTG EdgeSeq DLBCL Cell of Origin Panel HTG EdgeSeq DLBCL-COO-CE-IVD HTG EdgeSeq EGFR KRAS and BRAF Mutation Assay HTG EdgeSeq Immune Response Panel HTG EdgeSeq Immuno-Oncology Assay HTG EdgeSeq Immuno-Oncology Panel HTG EdgeSeq Lung Fusion Assay HTG EdgeSeq Lymphoma Panel HTG EdgeSeq miRNA Whole Transcriptome Assay HTG EdgeSeq miRNA Whole Transcriptome Panel HTG EdgeSeq miRNA WTA HTG EdgeSeq Mouse mRNA Tumor Response Panel HTG EdgeSeq Oncology Biomarker Panel HTG EdgeSeq PATH Assay HTG EdgeSeq Path Assay HTG EdgeSeq Precision Immuno-Oncology Panel HTG EdgeSeq Precision Immunol-Oncology Panel HTG EdgeSeq System HTG EdgeSeq System Oncology Biomarker Panel HTG EdgSeq Immuno-Oncology Assay HTP ibrutinib Ibrutinib Immune Cells Immune Checkpoint Inhibitors Immune Related Genes Immune Response Immune System Immune Tolerance Immune-related Colitis Immuno-Oncology immuno-oncology agents immunohistochemistry IHC IMMUNOSARC Immunotherapy Inflammation Integrins inverted papilloma IRF4 ISG JAVELINE bladder Juvenile Arthritis Kidney kikuchi-fujimoto disease Kruppel-like factor 5 Limb ischemia Liposarcoma Liquid Biopsy Liver liver disease liver tissue Lung Lung cancer Lupus Lymph Node Metastasis lymphatic Lymphocytes Lymphoid Neoplasia lymphoma Lymphoma lymphomas Machine Learning machine learning malignancy sinonasal malignant mCRC Mechanism of Action Melanoma Mesothelioma MET Method Comparison Microenvironment microRNA MicroRNA miR-122-5p miR-3937 miRNA miRNA WTA miRNA-375 Molecular Characterization Mouse Mouse mRNA mRNA mRNA custom mTOR pathway mTOR signaling multi-omics multiple myeloma Multiple Myeloma MUM1 Muscle mutation analysis Mutations MYC NAFLD Nash and Fibrosis native African men Natural Killer Cells Neoantigens Neuroendocrine Tumor Neurologic nivolumab NKG2A Non-alcoholic fatty liver disease non-Hodgkin Lymphoma Novel Therapeutic Targets NTRK1 nuclease protection assay OBP Oesophageal Adenocarcinoma Oncology Oncology-Biomarker OPSCC Oral Cancer Oral Squamous Cell Carcinoma Oropharyngeal Cancer Osteoarthritis Osteoclast Ovarian cancer PALLET PALOMA-2 Pan-Cancer PanB Pancreas Pancreatic Cancer Paralysis Parkinson's Disease Pathogenesis pathophysiology Pathway Analysis Pathway analysis Patient Stratification PAXgene PBMCs PCA Cell Lines PD-1 PD-L1 PENELOPE-B PFAS PIK3CA mutation PIP Placenta placenta Plasma Plasma miRNAs Platform Comparison PMAIP1 population based Precision medicine predictive biology Predictive Biomarkers Predictive Modeling Programmed cell death protein 1 Progression free-survival progression of renal failure Prostate Prostate Cancer prostate cancer prostate genomics Protein Protein Interaction network qNPA qPCR race disparities Radioimmunotherapy RAS Rearrangements Refractory DLBCL Relapsed DLBCL Renal Cell Carcinoma Renal Disease Reproductive Response rate RET Reveal Rheumatoid Arthritis Risk Score ROS1 safety sarcoma Sarcoma Sequencing Serum Signaling Inhibitors Signaling Pathways Signature Validation Signatures Sinonasal Carcinoma Skin soft tissue sarcoma SPECS Lung Consortium Squamous cell carcinoma squamous cell carcinoma STAT6 pathway Sub-typing surface plasmon Surveillance Survival Outcomes Survival plots Synovial Fluid Synovial Sarcoma synthetic miRNA T-Cell T-cells targeted therapeutics Technology Comparison Testicular cancer Therapeutic Response Therapeutic targets Thymic Carcinoma Thyroid Cancer tislelizumab TMB tomentosin Toxicity TP53 mutation Transcriptome transcriptome profiling Translational Medicine Transplantation Treatment Outcome Treatment Stratification Treatment Targets Tumor Biology Tumor Heterogeneity Tumor Immunobiology Tumor infiltrating lymphocytes tumor microenvironment Tumor Microenvironment Urine Urothelial carcinoma Uterus VEGFR Wound healing Xenograft Tissue Zanubrutinib

2011

Accurate Classification of Diffuse Large B cell Lymphoma into Germinal Center and Activated B cell Subtypes Using a Nuclease Protection Assay on Paraffin Embedded Tissues.

Rimsza L., et al. Accurate Classification of Diffuse Large B cell Lymphoma into Germinal Center and Activated B cell Subtypes Using a Nuclease Protection Assay on Paraffin Embedded Tissues. Clin Cancer Res. 2011 Jun 1:17(11)

PMID: 21364035

View External Link

Identification of ALK gene alterations in urothelial carcinoma (UC).

Bellmunt, J. Identification of ALK gene alterations in urothelial carcinoma (UC). J Clin Oncol. 2011 Sep 20;29(Suppl 27);abstr 4568. 

View External Link

2010

A Strategy for Full Interrogation of Prognostic Gene Expression Patterns: Exploring the Biology of Diffuse Large B Cell Lymphoma.

Rimsza L, et al. A Strategy for Full Interrogation of Prognostic Gene Expression Patterns: Exploring the Biology of Diffuse Large B Cell Lymphoma. PLoS One. 2011;6(8):e22267.

PMID: 21829609

View External Link

Identification of Potential Prognostic Biomarkers in Mantle Cell Lymphoma by Array-Based Quantitative Nuclease Protection Assay.

Yang D., et al. Identification of Potential Prognostic Biomarkers in Mantle Cell Lymphoma by Array-Based Quantitative Nuclease Protection Assay. Blood. 2010 Nov 19;116: abstr 2007.

View External Link

Xenobiotic-metabolizing enzyme and transporter gene expression in primary cultures of human hepatocytes modulated by ToxCast chemicals.

Rotroff D., et al. Xenobiotic-metabolizing enzyme and transporter gene expression in primary cultures of human hepatocytes modulated by ToxCast chemicals. J Toxicol Environ Health B Crit Rev. 2010 Feb;13(2-4):329-346.

PMID: 20574906

View External Link

2009

A Comparison of Gene Expression Pattern in Major Histocompatibility Class II-Low Diffuse Large B-Cell Lymphoma with Plasmablastic Lymphoma.

Wilkinson S., et al. A Comparison of Gene Expression Pattern in Major Histocompatibility Class II-Low Diffuse Large B-Cell Lymphoma with Plasmablastic Lymphoma. Blood. 2009;114:abstr 1941.

View External Link

Transcriptional Analysis of Intracytoplasmically Stained, FACS-Purified Cells by High Throughput, Quantitative Nuclease Protection.

Pechold S, et al. Transcriptional Analysis of Intracytoplasmically Stained, FACS-Purified Cells by High Throughput, Quantitative Nuclease Protection. Nat Biotechnol. 2009 Nov;27(11):1038-1042.

PMID: 19838197

View External Link

Precise Multiplexed Measurement of Gene Expression: Quantitative Nuclease Protection Assay (qNPA™).

Coker P., et al. Precise Multiplexed Measurement of Gene Expression: Quantitative Nuclease Protection Assay (qNPA™). Proceedings of the 35th Annual Meeting of the Plant Growth Regulation Society of America.

View External Link

Polyanionic Microbicides Modify Toll-Like Receptor-Mediated Cervicovaginal Immune Responses.

Trifonova R., et al. Polyanionic Microbicides Modify Toll-Like Receptor-Mediated Cervicovaginal Immune Responses. Antimicrob Agents Chemother. 2009 Apr;53(4):1490-1500.

PMID: 19139286

View External Link

2008

Insulin, IGF-1, and Muscarinic Agonists Modulate Schizophrenia-Associated Genes in Human Neuroblastoma Cells.

Altar C., et al. Insulin, IGF-1, and Muscarinic Agonists Modulate Schizophrenia-Associated Genes in Human Neuroblastoma Cells. Biol Psychiatry. 2008 Dec 15;64(12);1077-1087.

PMID: 18973876

View External Link

Page last updated September 29, 2022